Background/Aims: This study was conducted to investigate the relationship between differentially expressed proteins (DEPs) and the pathogenesis of oleic acid (OA)-induced acute lung injury (ALI) in mice. Methods: Eight-week-old male C57BL/6 mice were injected with OA through the tail vein and sacrificed 6 hours after OA administration to identify protein expression levels in lung tissue using isobaric tags for relative and absolute quantification (iTRAQ) technology. Then, DEPs such as antithrombin III (AT III), 12-lipoxygenase (12-LO), dedicator of cytokinesis 2 (DOCK2), polycystin-2 and plasminogen were identified by western blotting. Subsequently, we focused on investigating the effect of AT III on endothelial integrity using siRNA interference technology. The levels of IL-6, IL-1β, TNF-α and TGF-β expression were detected using an enzyme-linked immunosorbent assay (ELISA). Alterations in the tight junction component ZO-1 and the phosphorylation of myosin light chain (pMLC) were determined by western blotting. The stress fiber F-actin were also detected by immunofluorescence staining. In addition, endothelial permeability was determined via a transwell permeability assay. Results: A total of 5152 proteins were found to be expressed in lung tissues from the OA-treated and saline-treated mice. Among these proteins, 849 were differentially expressed between the two groups, including 545 upregulated and 304 downregulated proteins. After AT III knockdown, the levels of inflammatory factors and endothelial permeability were elevated, the expression of ZO-1 was decreased, and the expression of F-actin and pMLC was increased. All these results illustrated that AT III knockdown exaggerated the disruption of endothelial integrity mediated by OA. Conclusion: These findings using iTRAQ technology demonstrate, for the first time, differences in the lung tissue expression levels of proteins between OA-treated mice and saline-treated mice. This study reveals that 12-LO, DOCK2 and especially AT III may be candidate biomarkers for OA-induced acute lung injury.
ITRAQ-Based Proteomics Analysis of Acute Lung Injury Induced by Oleic Acid in Mice

Introduction
In 2001, the acute respiratory distress syndrome (ARDS) was redefined by experts convened in Berlin. The Berlin definition of ARDS included three categories based on degree of hypoxemia: mild (200 mm Hg < PaO 2 /FiO 2 ≤300 mm Hg), moderate (100 mm Hg < PaO 2 /FiO 2 ≤ 200 mm Hg), and severe (PaO 2 /FiO 2 ≤ 100 mm Hg). In addition, four ancillary variables were also used to assess the severe ARDS: radiographic severity, respiratory system compliance (≤40 mL/cm H 2 O), positive end-expiratory pressure (≥10 cm H 2 O), and corrected expired volume per minute (≥10 L/min) [1, 2] . ARDS is characterized by massive inflammatory cell infiltration, increased capillary permeability, severe alveolar damage and the formation of hyaline membranes [3] [4] [5] [6] . The primary insults leading to ARDS include microbial infection, pollutants, toxic gasses, gastric acids, autoantibodies, fatty emboli, free fatty acids and transfusion [7, 8] .
Within the past several years, isobaric tags for relative and absolute quantification (iTRAQ) technology has been used to investigate idiopathic pulmonary fibrosis [9] and hepatic ischemia-reperfusion-induced lung injury [10] . However, to our knowledge, no previous studies have used quantitative proteomics technologies to identify DEPs and their associated signaling pathways in OA-induced ALI.
To detect the potential biomarkers that could be likely implicated in the development of ARDS in this study, we present the first proteomics analysis of lung tissues using the iTRAQ approach, in which we identified a set of DEPs from the lungs of OA-treated and saline-treated mice. One study has demonstrated that intravenous injection of OA disrupts the endothelial barrier and causes severe lung edema [11] . In addition, the degree of abnormalities in coagulation and fibrinolysis proteins may strongly impact the outcomes of patients with ARDS [12] . Interestingly, the coagulation and complement pathways were among the top signaling pathways identified in this study. Moreover, it has been reported that antithrombin III (AT III), one upregulated component of the coagulation and complement pathways in our study, exhibits anti-inflammatory effect via decreasing the endothelial hyperpermeability of ALI in the animal models of burn and smoke inhalation [13] . Accordingly, we first validated the lung tissue expression levels of AT III by western blotting in OA-induced ALI, and then further confirmed the effect of AT III on OA -induced endothelial injury in human lung microvascular endothelial cells (HMVECs) by means of RNA interference technology. To further confirm the effect of AT III on OA -induced endothelial injury, human lung microvascular endothelial cells (HMVECs) were transfected with a specific siRNA against AT III. In our work, we found that the expression of AT III demonstrated by western blotting analysis were in accordance with that obtained using iTRAQ in the lung tissue, and knockdown of AT III exaggerated OAinduced endothelial cell integrity damage in HMVECs, suggesting that the expression levels and functional changes of AT III is related to OA-induced ALI. Our data showed that AT III may be a potential biomarker that could be likely implicated in the development of ARDS.
Materials and Methods
Cell culture
HMVECs were obtained from the Lonza (Walkersville, MD, USA). The HMVECs were grown in endothelial basal medium 2 (EBM 2) (Lonza) supplemented with endothelial growth medium SingleQuots and 5% FBS (Gibco BRL, MO). HMVECs were maintained at 37 °C in a humidified 5% CO 2 incubator.
Animals
Mice were purchased from the Shanghai SLAC Laboratory Animal Co. Ltd. and housed in a specific pathogen-free facility with 12-h light/dark cycles and free access to food and water. abundant precursor ions from the survey scan (350-1800 m/z) for HCD fragmentation. The automatic gain control (AGC) target was set to 3e6, and the maximum injection time was set to 50 ms. Survey scans were acquired at a resolution of 70, 000 at 200 m/z, the HCD spectra resolution was set to 17, 500 at 200 m/z, the isolation width was 2 m/z, and the normalized collision energy was 30 eV. Data analysis. The MS/MS spectra were searched using the MASCOT engine (Matrix Science, London, UK; version 2.5) embedded in Proteome Discoverer 2.1. Next, we performed a bioinformatics analysis of the identified proteins, and DEPs were defined in the iTRAQ experiment according to the following criteria: unique peptides ≥1, P-value <0.05, fold change >1.2 (or <0.8333). The DEPs were annotated using the Gene Ontology (GO) database (http://www.geneontology.org/), and protein classification was performed based on functional annotations using the GO terms for cellular components, biological processes and molecular functions. A Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of the DEPs was conducted using the KEGG database (http://www.genome.jp/kegg/).
Verification of proteins by western blot analysis
The perfused lung tissues were homogenized in lysis buffer with a glass homogenizer. The lysates were centrifuged at 12, 000 rpm for 10 min at 4 °C, and the supernatant was collected. The total protein concentration in the supernatant was quantified using a Pierce BCA protein assay kit. The protein extracts (50 μg/sample) were loaded on 10% gels for electrophoresis before transfer to PVDF membranes. The membranes were blocked with 5% dry milk in Tris-buffered saline with 0.1% Tween-20 for 2 h and incubated with specific primary antibodies against AT III (1:200; sc-365194, Santa Cruz), 12-LO (1:200; sc-365194, Santa Cruz), DOCK2 (1:200; sc-365242, Santa Cruz), polycystin-2 (1:200; sc-47734, Santa Cruz), plasminogen (1:200; sc-376405, Santa Cruz) and ZO-1(1:200, ab59720, Abcam) overnight at 4 °C, followed by incubation with a horseradish peroxidase-conjugated secondary antibody for 1 h. The loading control was the constitutively expressed β-actin protein (1:5000; Hangzhou HuaAn Biotechnology Co. Ltd.). The blots were visualized using an enhanced chemiluminescence system.
RNA interference and transfection
AT III siRNA oligonucleotides were synthesized by GenePharma (Shanghai, China). The target sequences were as follows: siRNA-802: 5'-CGAAUCACCGAUGUCAUUCTT-3'; siRNA-854: 5'-UGCUGGUUAACAC-CAUUUATT-3'; and siRNA-919: 5'-AAGGAACUGUUCUACAAGGTT-3'. The sequence 5'-UUCUCCGAACGUGU-CACGUTT-3' was used as a negative control siRNA. HMVECs were transfected with 100 nM siRNA using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. siRNA knockdown was confirmed by western blot 72 h after transfection, and only the most effective siRNA species was used in the following study.
Enzyme-linked immunosorbent assay (ELISA)
HMVECs were transfected with AT III siRNA and control siRNA for 72 h and then treated with OA (0.5 mmol/L) for an additional 24 h. The supernatants were collected for the measurement of IL-6, IL-1β, TNF-α and TGF-β concentrations by ELISA using commercially available ELISA kits (ExCell Biology, Inc., Shanghai, China). ELISA was performed according to the manufacturer's instructions. All samples from the AT III siRNA group and the control siRNA group were tested in triplicate.
Immunofluorescence staining
First, endothelial cells were plated on cover slips in 24-well plates and pretreated with 0.5 mmol/L OA for 24 h. The cells were then fixed with 4% paraformaldehyde for 10 min at room temperature (RT). The cells were blocked in 2% BSA for 2 h at RT and incubated overnight with a primary antibody against ZO-1 (1:100; ab59720, Abcam). Secondary antibodies (1:200; goat anti-rabbit IgG [Alexa Fluor 594], ab150080) were from Abcam. F-actin was stained with phalloidin labeled with rhodamine (Sigma, USA), and nuclei were stained with the DNA-binding fluorescent dye DAPI (Beyotime) at RT. After staining, the cells were washed three times with PBST and analyzed using a fluorescence microscope (Olympus, Tokyo, Japan).
FITC-dextran transwell permeability assay
A previously described transwell permeability assay was used to determine the degree of HMEC monolayer permeability [14] . Briefly, after transfection with AT III siRNA or control siRNA, HMVECs were Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry grown to confluency on matrigel-coated transwell inserts containing 3-μm pores (EMD Millipore) in a 24-well plate. Twenty-four hours after plating, FITC-labeled dextran (3 kDa, Invitrogen) and OA were added to the lower chamber to final concentrations of 10 μg/mL and 0.5 mmol/mL, respectively. Ten-microliter aliquots of medium were removed from the upper inserts, diluted in 90 μL of water/well in a 96-well plate 60 min after treatment, and then analyzed for fluorescence intensity by fluorometry.
Statistical analysis
The data are expressed as the means ± SD. A two-tailed Student's t-test was used to analyze differences between the two groups. P-values less than 0.05 were considered to indicate statistical significance.
Results
Successful establishment of OA-induced ALI model and volcano plots of DEPs
The histologic results indicated that lung tissues from OA-treated mice had massive inflammatory cell infiltration and fibrin deposition in the air space, thickened alveolar walls, edema, and formation of hyaline membranes compared with lung tissues from saline-treated mice. Based on the histologic and pathologic results, we determined that the OA-induced ALI model was well established (Fig. 1A) .
Volcano plots were created using P-values (−log10 P-value) versus the log2 fold change in each protein to compare the level of significance and magnitude of change across the global proteomes of the lung tissues between two groups. The volcano plots illustrated that a large proportion of proteins were remarkably upregulated or downregulated in the lung tissues of the OA-treatment group compared with those in the lung tissues of the salinetreatment group (Fig. 1B) .
Identification of DEPs
To verify the DEPs in OA-induced lung injury, total proteins from the lung tissues of the OA-treatment group and the saline-treatment group were extracted for iTRAQ analysis. In total, 5152 proteins were detected using iTRAQ. Compared with the saline group, the expression levels of 849 proteins were significantly different (upregulated ≥1.2-fold or downregulated ≤0.84-fold; P≤0.05) in the OA group. Specifically, 545 of the 849 proteins were upregulated (Table 1) , whereas the others were downregulated (Table 2) . A hierarchical clustering heat map of the DEPs is shown in Fig.  2 .
GO analysis of DEPs
The above DEPs were classified according to their biological processes, cellular components and molecular functions using the David database ( Table 2 .
The list of down-regulated differentially expressed proteins between OA group and control group by iTRAQ analysis Fig. 4 
KEGG pathway analysis of DEPs
A KEGG pathway map was applied to determine the pathways related to these DEPs. The top 20 KEGG pathways are listed in Fig. 5 . The results of the KEGG analysis showed that the 
Proteomics of OA-Induced ALI complement and coagulation cascade pathways were the predominant processes associated with the DEPs. The cytokine-cytokine receptor interaction and ECM-receptor interaction pathways were also identified.
Western blot validation
Based on the KEGG pathway and fold change analyses, the lung expression levels of AT III, 12-LO, DOCK2, polycystin-2 and plasminogen were selected for further validation. The results showed that the expression levels of these DEPs were remarkably increased in the OA-treatment group compared with those in the control group (Fig. 6A) . In addition, in HMVECs exposed to 0.5 mmol/L OA, AT III expression was significantly enhanced in the OA-treatment group compared with that in the control group (Fig. 6B) . The quantification of the verified proteins was highly inconsistent with the proteomic results. However, the roles and mechanisms of these upregulated proteins in OA-induced lung injury remain poorly understood. Previous studies have shown that the primary pathogenesis of sepsis involves the initiation of the coagulation cascade, followed by pro-inflammatory cytokine production [15] . Satoshi Hagiwara also reported that AT III suppressed LPS-induced activation of the nuclear factor (NF)-κB pathway by preventing phosphorylation of the IKK pathway, and this may possibly inhibit the secretion of HMGB1 and improve endotoxin-induced ALI in rats [16] .
AT III knockdown increases cytokine secretion
To further elucidate the role of AT III in OA-induced endothelial inflammation and integrity, we utilized a specific siRNA to silence AT III expression. AT III knockdown was validated by western blot analysis of whole-cell lysates from non-specific (control) siRNAand AT III-specific siRNA-transfected endothelial cells. As shown in Fig. 7A , the knockdown effect of AT III siRNA-919 was the most effective; therefore, this siRNA was used in the following study. To detect the effects of AT III on the release of inflammatory factors in OA- Fig. 4 . Gene ontology (GO) enrichment analysis. The GO terms of most significantly differentially expressed proteins (DEPs) identified from the comparison between the OA-treatment and control groups were mainly enriched in the extracellular region, followed by the extracellular region part and immune system processes.
Figure 4
treated endothelial cells, culture supernatants from HMVECs that had been transfected with AT III siRNA or control siRNA and then treated with OA were collected, centrifuged and subjected to IL-6, IL-1β, TNF-α and TGF-β ELISA. Compared with the control siRNA group, the levels of IL-6, IL-1β, TNF-α and TGF-β in the culture supernatants were significantly increased 24 h after the administration of OA in the AT III siRNA group (Fig. 7B, 7C , 7D and 7E; P<0.05), which suggested that knockdown of AT III increased cytokine secretion in OAstimulated endothelial cells.
AT III knockdown impairs endothelial integrity
Endothelium intracellular junctions, such as endothelial tight junctions and adherent junctions, maintain the barrier function of the endothelium and regulate endothelial cell contraction [17, 18] . Endothelial hyperpermeability is specifically caused by cell junction breakdown, which ultimately leads to the formation of intracellular gaps [19] . Endothelial tight junctions are composed of the tetraspan transmembrane proteins claudin and occludin, the latter of which maintains the integrity of the endothelium in the blood-brain barrier [20] . Adherens junctions maintain the mechanical strength of intracellular adhesion by homophilic Ca
2+
-dependent trans-interactions with VE-cadherin [21] . Both endothelial tight junctions and adherens junctions interact with the cortical actin cytoskeleton through adaptor molecules, such as the tight junction components ZO-1, -2, and -3 and the catenin family members α-, β-, and γ-catenin [22] . In this study, the expression of the tight junction protein ZO-1 was markedly decreased (Fig. 8A) , whereas the expression of the stress fiber F-actin (Fig. 8B ) was significantly increased in the AT III siRNA group compared with that in the control siRNA group. Additionally, endothelial cell integrity was examined using a FITC-dextran transwell permeability assay. (Fig. 8C ) In this assay, which monitors the passage of a small molecule, FITC-labeled dextran, through endothelial cells on matrigel-coated transwell inserts containing 3-μm pores, we found that FITC-labeled dextran permeability was markedly increased in the AT III siRNA group compared with that in the control siRNA group (P<0.05), suggesting that AT III knockdown increased endothelial cell permeability. In addition, compared with the control group, the expression of phosphorylated myosin light chain (pMLC) was notably increased in the AT III siRNA group (Fig. 8D) .
Discussion
This study represents the first-ever investigation of lung tissue proteomic profiles from mice with OA-induced ALI using iTRAQ and nano-LC-MS/MS techniques to detect potential biomarkers and elucidate the molecular alterations that occur following lung injury. Interestingly, we identified and quantified lung tissue proteins that were differentially expressed in the OA-treatment group mice compared with those in the saline-treatment group.
Although the exact mechanisms by which abnormalities in coagulation and fibrinolysis proteins contribute to patient outcomes in ALI are not well established, a previous study indicated that coagulation and the inflammatory cascade may affect the pathogenesis of ALI and ARDS [12] . Some experimental evidence has revealed that abnormalities in the pro-coagulation and fibrinolysis protein pathways are features of ALI [23, 24] . ALI is accompanied by fibrin deposition in the lung and increased plasminogen activator inhibitor expression in bronchoalveolar lavage (BAL) fluid. Intriguingly, by applying the iTRAQ approach to identify Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry relevant KEGG pathways, we found that the coagulation and complement pathways were among the top signaling pathways identified in the present study. One upregulated component of the coagulation and complement pathways was AT III. AT III, encoded by SerpinC1, is an important anti-coagulation molecule and serine protease inhibitor in the coagulation cascade [25, 26] . Moreover, there is evidence demonstrating that AT III exerts anti-inflammatory effects, at least partially, by increasing the level of PGI 2, suppressing NF-κB, decreasing leucocyte-endothelial interactions, and inhibiting microvascular leakage [27] [28] [29] [30] [31] . Wang et al. [32] noted that SerpinC1 insufficiency aggravated renal ischemia/reperfusion injury by increasing renal oxidative stress, tubular apoptosis, and macrophage infiltration. Nevertheless, continuous infusion of rhAT III attenuated neutrophil activation, adhesion and transendothelial migration and thereby reduced endothelial hyperpermeability of ALI following burn and smoke inhalation in animal models [13] . The potential mechanism of action may be the interaction between rhAT III with the syndecan-4 receptor on endothelial cells and neutrophils. Using in vivo and in vitro experiments, we confirmed that AT III was upregulated in the OA-treatment group compared with that in the saline-treatment group. To further identify the role of AT III in OA-induced inflammatory responses, we utilized AT III-targeted siRNA. We found that AT III knockdown exaggerated OA-induced inflammatory responses, as demonstrated by increased production of inflammatory cytokines, such as IL-6, IL-1β, TNF-α and TGF-β.
From an analysis of the coagulation and complement signaling pathways, we observed that AT III is associated with not only inflammatory responses but also endothelial permeability. It has been reported that intravenous injection of OA has a direct toxic effect on vascular endothelium within minutes, which leads to permeability edema [33, 34] . In this study, we also found that FITC-labeled dextran permeability markedly increased in the AT III knockdown group compared with that in the control siRNA group. It is well known that cellular tight junctions are critical for the stabilization of endothelial barrier function. ZO-1, which plays a crucial role in forming tight junctions, also regulates angiogenesis and endothelial barrier formation [35] [36] [37] [38] . Using in vitro experiments, we determined that when endothelial cells were exposed to OA, the expression of ZO-1 was decreased in the control siRNA group, and this effect was further exacerbated in the AT III siRNA group. In addition, cytoskeletal F-actin stress fibers possibly lead to pulmonary endothelial hyperpermeability. Some evidence has indicated that regulation of F-actin stress fiber formation is partially Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry associated with endothelial barrier function, but the exact mechanism underlying this process is poorly understood [39] . Our results illustrated that AT III knockdown enhanced the formation of F-actin stress fibers in endothelial cells exposed to OA. These findings suggest that AT III has a protective role in endothelial cell permeability, possibly via interactions with ZO-1 and the F-actin cytoskeleton. Dudek et al. [40, 41] showed that thrombin induced disruption of the endothelial barrier, which caused physiological dysfunction such as hypoxemia, atherosclerosis, and pulmonary edema, a typical characteristic of ALI. Van Hinsbergh et al. [42] noted that the possible mechanism of histamine-induced transient short-term hyperpermeability involved Ca 2+ /calmodulin-dependent activation of the myosin light chain (MLC) kinase. The cause of thrombin-induced endothelial hyperpermeability involved activation of the small GTPase RhoA and Rho kinase, which increased the phosphorylation of MLC. In addition, Parker et al. [43] demonstrated that thrombin induced endothelial barrier destabilization, at least partly, by inhibiting the activation of Rap1 and Rac1 and increasing the phosphorylation and distribution of VE-cadherin, the phosphorylation of MLC, and actin polymerization. Consistent with the results of previous studies, we observed that after endothelial cells were exposed to 0.5 mmol/L OA, the expression of pMLC was increased in the AT III siRNA group compared with that in the control siRNA group.
In short, AT III knockdown exaggerated OA-induced inflammatory responses, as demonstrated by increased production of inflammatory cytokines, such as IL-6, IL-1β, TNF-α and TGF-β; enhancement of endothelial hyperpermeability, as indicated by increased passage of FITC-labeled dextran and phosphorylation of MLC; decreased expression of ZO-1; and increased expression of F-actin stress fibers.
The present study demonstrated that most of the verified DEPs may serve as therapeutic targets for ALI. For instance, after endothelial cells were exposed to OA, we observed that the expression of AT III increased in vivo and in vitro, whereas AT III knockdown exaggerated inflammatory responses and endothelial integrity dysfunction. We think that, to some degree, AT III may attenuate endothelial hyperpermeability and further maintain endothelial integrity during thrombin-induced disruption of endothelial barrier function. In future studies, we will focus on identifying the relationship between these proteins and the pathogenesis of OA-induced ALI to provide guidelines for treating patients with ALI.
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